Hyperfine, Inc. (HYPR) – What Are Investment Firms Thinking About This Stock?

Hyperfine, Inc. (NASDAQ:HYPR) has been given a consensus recommendation of “Hold” by the five research firms that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $2.03.

A number of research firms have commented on HYPR. BTIG Research reissued a “buy” rating and set a $2.00 target price on shares of Hyperfine in a research report on Tuesday, September 22nd. B. Riley Financial restated a “buy” rating and set a $1.60 price objective (down from $2.00) on shares of Hyperfine in a research note on Monday, August 10th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Hyperfine in a research report on Friday, July 17th.

Hyperfine Price Performance

HYPR opened at $0.85 on Wednesday. The company has a market capitalization of $90.30 million, a price-to-earnings ratio of -2.24 and a beta of 1.45. The company has a current ratio of 6.15, a quick ratio of 5.45 and a debt-to-equity ratio of 0.36. Hyperfine has a 12-month low of $0.75 and a 12-month high of $2.22. The business’s fifty day simple moving average is $0.86 and its 200-day simple moving average is $1.15.

Hyperfine (NASDAQ:HYPR) last released its quarterly earnings data on Thursday, August 6th. The company reported ($0.09) earnings per share for the quarter, meeting the consensus estimate of ($0.09). Hyperfine had a negative return on equity of 97.88% and a negative net margin of 210.75%. The firm had revenue of $3.90 million during the quarter, compared to the consensus estimate of $4.13 million. On average, equities research analysts anticipate that Hyperfine will post -0.34 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Hyperfine

Several institutional investors and hedge funds have recently bought and sold shares of HYPR. Catalio Capital Management LP increased its stake in Hyperfine by 92.8% during the 4th quarter. Catalio Capital Management LP now owns 1,320,041 shares of the company’s stock valued at $1,293,000 after purchasing an additional 635,500 shares in the last quarter. Renaissance Technologies LLC lifted its stake in shares of Hyperfine by 100.2% during the first quarter. Renaissance Technologies LLC now owns 730,233 shares of the company’s stock worth $789,000 after buying an additional 365,490 shares during the period. Bank of New York Mellon Corp acquired a new stake in shares of Hyperfine during the second quarter worth $419,000. Finally, Walleye Capital LLC lifted its stake in shares of Hyperfine by 3.4% during the first quarter. Walleye Capital LLC now owns 223,988 shares of the company’s stock worth $242,000 after buying an additional 7,330 shares during the period. 15.03% of the stock is owned by hedge funds and other institutional investors.

About Hyperfine

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on making magnetic resonance imaging (MRI) more accessible and convenient. Its flagship product, the Swoop Portable MR Imaging System, is designed to provide brain imaging at or near the patient’s bedside rather than requiring transport to a traditional MRI suite.

The Swoop system uses a low-field magnetic resonance platform, artificial intelligence-enabled image processing and a mobile design to support neuroimaging in settings such as hospitals, intensive care units and other clinical environments.